Literature DB >> 8277937

Drug-resistant Streptococcus pneumoniae--Kentucky and Tennessee, 1993.

.   

Abstract

Streptococcus pneumoniae is the most common bacterial cause of pneumonia worldwide in children and adults and a leading cause of sepsis and meningitis. In addition, it is the etiology of 30%-50% of episodes of acute otitis media, the most frequent reason for pediatric office visits in the United States (approximately 24.5 million per year). Because sensitive and rapid diagnostic tests are not available, most pneumococcal infections are treated empirically; until recently, penicillin (PCN) and related drugs have been the treatment of choice. However, because of the emergence of infections with drug-resistant S. pneumoniae (DRSP), decisions regarding the management of infections caused by this pathogen have become increasingly complicated. This report summarizes results of recent investigations by CDC and state public health officials of DRSP in communities in Kentucky and Tennessee.

Entities:  

Mesh:

Year:  1994        PMID: 8277937

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  13 in total

1.  Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species.

Authors:  M J Mohammed; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 2.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

3.  Activity of vancomycin, teicoplanin and cephalosporins against penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae.

Authors:  V G Loo; J Lavallée; D McAlear; H G Robson
Journal:  Can J Infect Dis       Date:  1995-03

Review 4.  The best of times, the worst of times. The global challenge of antimicrobial resistance.

Authors:  F C Tenover
Journal:  Pharm World Sci       Date:  1995-09-22

Review 5.  Resistant Pneumococcus: a worldwide problem.

Authors:  G E Schutze; S L Kaplan; R F Jacobs
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

6.  Factors associated with antibiotic use for acute bronchitis.

Authors:  R Gonzales; P H Barrett; L A Crane; J F Steiner
Journal:  J Gen Intern Med       Date:  1998-08       Impact factor: 5.128

7.  Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.

Authors:  M R Jacobs; R Dagan; P C Appelbaum; D J Burch
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

8.  Reporting Emerging Resistance of Streptococcus pneumoniae from India.

Authors:  Kiran Chawla; Bimala Gurung; Chiranjay Mukhopadhyay; Indira Bairy
Journal:  J Glob Infect Dis       Date:  2010-01

9.  Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.

Authors:  James A Karlowsky; Mark E Jones; Deborah C Draghi; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Cephalosporin-resistant pneumococci and sickle cell disease.

Authors:  Martha L Miller; Caroline A Obert; Geli Gao; Najat C Daw; Patricia Flynn; Elaine Tuomanen
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.